Drug Injury Law: FDA And MHRA Actions For Gadolinium-Containing Contrast Agents Differ

Drug Injury Law: FDA And MHRA Actions For Gadolinium-Containing Contrast Agents Differ http://www.drug-injury.com/druginjurycom/2017/12/omniscan-recall-magnevist-drug-retention-gadolinium-containing-contrast-agents-optimark-mhra-fda-safety-regulatory-actions.html
Contributor
Tom Lamb
Wilmington, North Carolina
Personal Injury
910-256-2971

About
I have a national litigation practice based in Wilmington, North Carolina, representing people who have cases involving prescription drug injury lawsuits and asbestos-mesothelioma claims.